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Abstract 
Background - Apamin-sensitive small conductance calcium-activated K current (IKAS) is 
upregulated during ventricular pacing and masks short-term cardiac memory (CM).  
Objective – To determine the role of IKAS in long-term CM.   
Methods – CM was created with 3-5 weeks of ventricular pacing and defined by a flat or 
inverted T-wave off pacing. Epicardial optical mapping was performed in both paced and 
normal ventricles. Action potential duration (APD80) was determined during A pacing. 
Ventricular stability was tested before and after IKAS blockade.  Four paced hearts and 4 
normal hearts were used for western blotting and histology.  
Results – There were no significant differences in either the echocardiographic parameters 
or in fibrosis levels between groups.  Apamin induced more APD80 prolongation in CM than 
in normal ventricles (9.6% [8.8%-10.5%] vs 3.1% [1.9%-4.3%], p<0.001). Apamin significantly 
lengthend the APD80 in the CM model at late activation sites, indicating significant IKAS 
upregulation at those sites. The CM model also had altered Ca2+ handling as the 50% Ca2+ 
transient duration and amplitude were increased at distal sites compared to a proximal site 
(near the pacing site).  After apamin, the CM model had increased VF inducibility (paced vs 
control, 33/40 (82.5%) vs 7/20 (35%) P<0.001), and longer VF durations (124 vs 26 seconds, 
P<0.001).  
Conclusions - Chronic ventricular pacing increases Ca2+ transients at late activation sites 
which activates IKAS to maintain repolarization reserve. IKAS blockade increases VF 
vulnerability in chronically paced rabbit ventricles.  
Keywords: cardiac memory; electrophysiology; ventricular fibrillation; ion channels 
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Introduction 
Unnecessary right ventricular (RV) pacing may cause cardiomyopathy in patients with 
preserved left ventricular systolic function1 and increased morbidity and mortality in patients 
with reduced ejection fraction with implantable cardioverter-defibrillators.2 The mechanisms 
of the detrimental effects of ventricular pacing remain incompletely understood. Ventricular 
pacing is known to produce both short and long term cardiac memory (CM) characterized by 
T-wave changes associated with altered activation sequence.3 Recent studies have shown 
that ventricular pacing is associated with cytosolic calcium (Cai) accumulation at late 
activation sites.4 The increased Cai can cause significant changes of cardiac repolarization, 
including increased sodium-calcium exchange current (INCX) that tend to prolong the action 
potential duration (APD) and promote afterdepolarizations.5 On the other hand, the increased 
Cai could also activate apamin sensitive small conductance Ca2+ activated K (SK) current 
(IKAS), which helps to reduce the APD and preserve the repolarization reserve.6 Because of 
the presence of these two opposing effects, ventricular pacing can cause transient APD 
prolongation at late activation sites leading to a positive APD-activation time (AT) relationship 
(short term CM) within 5-min of pacing.7 Continued pacing for an hour or more can normalize 
the APD-AT relationship due to IKAS upregulation in late activation site.6 Therefore, short term 
CM is transient and is well compensated by the upregulation of IKAS. However, the mechanism 
of long term CM remains unclear. We hypothesize that IKAS is upregulated at late activation 
sites during chronic ventricular pacing in rabbit ventricles but is of insufficient magnitude to 
suppress the manifestation of CM. Apamin, which blocks IKAS, aggravates APD prolongation 
at the late activation sites, reduces repolarization reserve and increases ventricular 
vulnerability to fibrillation. The purpose of the present study was to test these hypotheses.  
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Methods 
The study protocol was approved by the Institutional Animal Care and Use Committee of 
Indiana University School of Medicine and the Methodist Research Institute, Indianapolis, 
Indiana, and conformed to the regulations for humane care and treatment of animals 
established by the NIH. A total of 29 female New Zealand white rabbits (3.5-5.0 kg) were 
used in this study. Among them, 20 were used for chronically ventricular pacing and 9 normal 
rabbit hearts that were not paced were used as controls.  A detailed methods section is 
included in the Online Supplement.  
Pacing-Induced long-term CM and Optical Mapping 
Ventricular epicardial pacing of either the right ventricle (n=9) or the left ventricle (n=11) was 
used to induce long-term CM.8  Ventricles were paced at 270 beats per min (bpm) for 3-5 
weeks.  Each week, the T-wave from ECG Lead II was assessed.  Chronic CM was defined 
by either a flat or inverted T-wave (Figure 1).  Echocardiography was performed both before 
the pacemaker implantation and at follow up.  Optical mapping was performed on both 
paced hearts and normal hearts of both the RV and LV (Online Supplement Figure 1) as 
previously described.8  Excised hearts were
 
Langendorff perfused at 25 to 35 mL/min with 
Tyrode’s solution and stained with Rhod-2 AM (1.48 µmol/L) for Cai and RH237 (10 µmol/L) 
for Vm mapping. Contractility was blocked with blebbistatin (15 – 20 µmol/L). To prevent 
induction of short term CM the hearts remained in normal sinus rhythm except for specific 
programmed stimulation during optical recordings.6   
Protocol I – Electrophysiological Effects of Cardiac Memory 
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The CM model was created in 7 hearts with RV pacing and 3 hearts with LV pacing to 
determine if LV pacing showed the same characteristics as RV paced hearts.  Five normal 
hearts were used as controls.  The ventricular APD80 was determined in each heart by 
pacing the right atrial appendage at 300 ms, and optical maps were acquired after at least 30 
paced beats.  To determine the role of IKAS, apamin (100 nmol/L) was then added to the 
perfusate and the protocol was repeated after 30 minutes. At that concentration, apamin is a 
highly specific IKAS blocker.9  After radiofrequency ablation of the atrioventricular (AV) node, 
pacing was performed from the RV apex.  A S1/S2/S3 (short/long/short) pacing protocol (S1 
30 beats with S1-S1 300 ms, a long S1-S2 of 1000 ms or 2000ms and a S2-S3 starting from 
300 ms and gradually shortened to the ventricular effective refractory period (ERP)) was used 
to simulate the ECG characteristics that initiates early after-depolarizations (EADs) and 
torsades de pointes (TdP) ventricular tachycardia in the clinical setting.10 Finally, a dynamic 
ventricular pacing protocol was used to determine arrhythmia inducibility.  If VF was not 
induced, burst pacing (PCL 50 ms, pacing duration 10 s) was used to induce VF.  Any VF 
that occurred was allowed to continue for 180 s before a defibrillation attempt was made.  
After the return to sinus rhythm, the heart was allowed to rest for 1 min before continuing the 
pacing protocol.  VF induction was attempted 4 times in each heart.  Phase singularities 
(PS) were used to quantify VF characteristics.11      
Protocol II – Effects of Cardiac Memory on Arrhythmia Inducibility 
In protocol I, all arrhythmia inducibility data was acquired after apamin infusion.  To 
determine the effects of CM on arrhythmia inducibility and the role of IKAS, 3 additional hearts 
with chronic LV pacing were used to acquire data on ventricular stability at baseline and after 
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apamin infusion.  In each heart, AV nodal ablation was performed, and to determine the 
inducibility of any EADs and VF, ventricular pacing was performed as described in protocol I.  
Any ventricular arrhythmias that resulted from the pacing were noted and then apamin (100 
nmol/L) was added to the perfusate and the protocol was repeated after 30 min.   
Western Blotting  
Among the 3 different subtypes of SK channels, SK2 is known to be the most sensitive to 
apamin and contribute the most to IKAS.12  To determine the protein expression of SK2 
channels within the myocardial tissue, Western blotting was performed on tissue acquired 
from sites distal and proximal to the chronic pacing site in 4 chronically paced hearts and from 
similar areas in 4 normal hearts.13   
Histology 
For histology, ventricular tissue from 4 normal hearts and 4 chronically paced hearts was 
embedded in paraffin, sectioned and stained using Masson's trichrome stain.  The collagen 
content was quantified by identifying and counting the number of blue-staining pixels as a 
percentage of the total tissue area using digital photomicrographs in Adobe Photoshop CS6 
software.  
Quantitative PCR 
Quantitive polymerase chain reaction (PCR) was used to determine the expression of 
transcripts encoding kcnn2 (SK2) and kcnn3 (SK3) in tissue acquired from sites distal and 
proximal to the chronic pacing site in 3 chronically paced hearts. 
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Statistical Analysis 
Data are presented as mean and 95% confidence interval (CI).  Paired Student t tests were 
used to compare variables measured at baseline and after apamin infusion.  An 
independent-sample t test was used to compare variables measured between groups.  A 
one way ANOVA was used to compare SK2 protein expression between different groups, and 
a paired t-test was used to compared RNA levels between the proximal and distal sites.  
Categorical parameters between groups comparing VF vulnerability were compared by either 
a chi-square test or the Fisher exact test.  A 2-sided P value of ≤0.05 was considered 
statistically significant. 
 
 
 
Results 
All rabbits survived the chronic pacing protocol.  Long term CM was assessed by T-wave 
changes in the ECG (flat or inverted T-wave after pacing). As shown in Figure 1, after 28 days 
of ventricular pacing, the ECG shows a T-wave that changed to flat or inverted in both RV and 
LV paced hearts. There were no significant differences in echocardiographic based 
measurements of LV size and function between baseline and after chronic pacing. Ventricles 
demonstrated an LV end-diastolic dimension of 12.2 mm [95% CI, 11.3–13.3] vs 12.1 mm [95% 
CI,11.4–12.8], for 3-5 weeks pacing and baseline, respectively; P=0.649), end-systolic 
dimension (8.2 mm [95% CI, 7.3–9.1] vs 8.0 mm [95% CI, 7.4–8.7]; P=0.637), fractional 
shortening (32.9% [95% CI, 29.4–36.4] vs 32.4% [95% CI, 28.6–36.2]; P=0.81) and ejection 
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fraction (69.3%[95% CI, 64.5–74.1] vs 69.6% [95% CI, 64.3–74.9] P=0.907).  From 
histological analysis shown in Figure 1B, there was no difference in the amount of fibrosis 
between chronically paced hearts and normal hearts.  
Effects of Apamin on the APD in CM  
Figure 2A shows APD80 maps (measured during RA pacing at 300 ms PCL) before and after 
apamin infusion in normal ventricles, in RV paced ventricles and in LV paced ventricles 
studied in Protocol 1. Corresponding optical tracing of action potentials from a single 
representative pixel from the site marked with an “A” are also shown in the figure.  At 
baseline, the APD80 distant from the pacing site had no or minimal prolongation while the 
APD80 closer to the pacing site was prolonged. After apamin, the APD80 was prolonged 
throughout the mapped region, indicating significant IK S upregulation at sites remote from 
pacing (arrows) in both RV and LV paced ventricles. There was little or no APD80 prolongation 
in normal ventricles. Figures 2B-2D summarize the effects of chronic pacing on APD80 
distribution at an atrial pacing cycle length (PCL) of 300 ms in all ventricles studied in Protocol 
I.  As the summary data shows, apamin induced more APD80 prolongation in paced 
ventricles than in normal ventricles (paced vs Normal, 9.6% [8.8%-10.5%] vs 3.1% 
[1.9%-4.3%], p<0.001, Figure 2D), with no differences between RV and LV paced ventricles. 
APD heterogeneity has been shown to be an important factor that contributes to increased 
vulnerability to ventricular arrhythmias.14 Figure 2C shows that after apamin the standard 
deviation (SD) of APD80 significantly increased at 300 PCL in CM hearts, but not in normal 
hearts.   
Characteristics of Ca2+ distribution in the CM model 
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We investigated the effects of the chronic pacing on the Ca2+ cycling characteristics by 
comparing the 50% Ca2+ transient duration (CaTD50).  Sample Ca2+ signals from a normal 
heart and a paced heart are shown in figure 3.  Overlapping the signals demonstrates that 
both RV and LV paced hearts have a longer CaTD50 than normal hearts.  Summary data in 
panel C shows a significant increase in the CaTD50 in paced hearts compared to normal 
hearts.  Ca2+ signals recorded with optical mapping also revealed a spatial gradient of the 
Ca2+ transients in the paced hearts.  In both the RV and LV chronically paced hearts, Ca2+ 
fluorescence was increased at distal sites (site remote from the pacing site) compared to 
proximal sites (near the pacing site) .  However, this relationship did not exist in the normal 
ventricles.  Sample normalized Ca2+ signals (F/F0) from both the proximal and distal 
locations are shown in Figure 4. For all chronically paced ventricles, the F/F0 measured was 
1.070 (N=10, CI 1.052-1.088) near the chronic pacing site (early activation site), which was 
significantly lower than the F/F0 (1.103, N=10, CI 1.084-1.123, P<0.001) measured at the 
opposite site of the ventricle (late activation sites).   
 
Chronic ventricular pacing is proarrhythmic  
In protocol I, a dynamic ventricular pacing protocol was used to determine arrhythmia 
inducibility between normal and paced hearts.  For all hearts studied, after apamin, paced 
ventricles developed APD alternans (Figure 5A) at a longer PCL than the control group 
(232ms [CI, 194–270] vs 180 [95% CI, 160–200 P=0.006] (Figure 5B).  No spontaneous 
arrhythmias were observed during the study.  In 10 paced hearts and 5 normal hearts, VF 
induction was attempted in each heart 4 times.  VF vulnerability increased (paced vs control, 
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33/40(82.5%) vs 7/20(35%) P<0.001) (Figure 5C), with a longer duration in paced hearts 
compared to control hearts (124 vs 26 seconds, P<0.001) (Fig 5D).  
In protocol II, 3 additional hearts were studied to investigate ventricular vulnerability to 
fibrillation at baseline and after apamin infusion.  Figure 6A shows representative examples 
of optical mapping traces at baseline and after addition of apamin demonstrating a significant 
prolongation of the APD80 at a PCL of 1000 ms after apamin infusion.  At baseline, only one 
of the three paced hearts developed a TdP arrhythmia.  However, after apamin infusion, all 
of the three paced hearts developed a TdP arrhythmia during short-long-short pacing.  An 
example of TdP induced with short-long-short pacing is shown in Figure 6B . In addition, the 
site of earliest activation of the TdP occurred at the sites farthest from the chronic pacing site 
(Figure 6C).  In these 3 CM hearts, there were 5 VF episodes at baseline and 11 episodes 
after apamin infusion.  Examples of phase maps during VF with marked phase singularities 
(black arrows) at baseline and after apamin infusion is shown in Figure 7A and 7B. Figure 7C 
summarizes the number of phase singularities in all hearts studied in Protocol II. There was a 
significant increase of phase singularities after apamin.  
 
SK2 Protein and RNA Expression 
Western blotting was performed in 4 normal hearts and 4 chronically paced hearts (2 RV 
pacing and 2 LV pacing).  As the results in Figure 8 show, there was no significant difference 
in the SK2 protein expression between normal and chronically paced hearts.  However, 
qPCR analysis showed that there was a significant increase in both SK2 (0.20 [95% CI, 
0.08-0.31] vs. 0.27 [95% CI, 0.21-0.32], p=0.048) and SK3 (0.21 [95% CI, 0.13-0.28] vs. 0.24 
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[95% CI, 0.13-0.34], p=0.045) levels at the distal site compared to the proximal site.   
Discussion 
This study has shown that CM develops with persistent ventricular pacing, which results in a 
repolarization gradient across the epicardial surface during atrial pacing, with the longest 
APD80 near the chronic pacing site and the shortest APD80 at the distal sites within the 
mapping field of view. Infusion of IKAS inhibitor apamin significantly lengthened the APD80 with 
the greatest increase of APD80 at the locations distal from the chronic pacing site.  In 
addition, an increase in the Ca2+ transients was also observed at these distal sites. Putting 
this information together, chronic pacing resulted in Cai accumulation and a robust activation 
of IKAS at late activation sites. Because of the increased IKAS, the late activation sites had a 
shorter APD than the early activation sites. This abnormal distribution of APD persisted when 
ventricular pacing was turned off, resulting in longer APD80 at the apical pacing sites than at 
the base. This abnormal distribution of APD80 results in abnormal patterns of T-waves during 
sinus or atrially paced rhythms (chronic CM).  
IKAS blockade and ventricular vulnerability to fibrillation 
In paced ventricles, inhibiting IKAS increased VF vulnerability and the incidence of TdP 
induced with EADs.  These data support that IKAS plays a significant compensatory role in 
CM and protects against arrhythmia initiation.  Several commonly used drugs, including 
amiodarone15 and ondansetron,16 are known to block IKAS.  Whether or not IKAS inhibition 
increases arrhythmia risk for pacemaker patients deserves further investigation. 
Mechanisms of cardiac memory 
CM is characterized by a change in T-wave morphology resulting from either 
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electrophysiological or structural remodeling induced by either ventricular pacing or 
myocardial stretch.17, 18  Varying degrees of CM has been shown after minutes to hours of 
pacing (producing “short-term” CM) and after 2 to 5 weeks of pacing (“long-term” CM). Two 
weeks of pacing is required to achieve a steady-state change in the T-wave. Molecular 
mechanisms of CM have been extensively reviewed recently.19,20 Short-term CM that is 
observed within minutes of ventricular pacing is thought to occur from modulation and 
modification of angiotensin II which has been shown to regulate Ito. Long-term CM, seen after 
longer periods of ventricular pacing and is longer lasting (days to weeks), includes alterations 
in AT1 receptors, stretch-activated receptors,21, 22 connexins23, 24 and in ion channels 
specifically Ito, Ikr, and ICa,L which results in an altered repolarization gradient.  The 
mechanisms underlying this ion channel remodeling revolves around changes in gene 
transcription and protein synthesis.19,20 This study is the first to show that in addition to the 
currents mentioned above, IKAS may also play a role in long-term CM.   
Clinical Implications   
This study provided new insights into the mechanisms of CM. The importance of IKAS in 
human ventricular repolarization is supported by a previous study that showed apamin 
prolonged the APD in the failing human ventricular myocardium.25  In CM models, we have 
observed an increased APD heterogeneity, steepened maximal slope of APDR, increased 
PCL threshold for alternans and increased spatially discordant APD alternans after IKAS 
inhibition, factors which increase vulnerability to ventricular arrhythmias. These findings 
suggest drugs that block IKAS may be unsafe for patients with chronic ventricular pacing. A 
second clinical implication is that IKAS upregulation helps to shorten the APD80 and counteract 
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the detrimental effects of Ca2+ accumulation at sites distal from pacing. Therefore, only a 
minority of patients develop pacing-induced cardiomyopathy after prolonged periods of RV 
pacing.1  
Study Limitations 
We only studied the acute effects of apamin in an ex vivo perfused heart model.  We did not 
investigate the chronic administration of a SK channel blocker in an ambulatory cardiac 
memory model.  In addition, we did not investigate SK1 or SK3 protein levels as a reliable 
antibody is not available for rabbit hearts.   
Conclusions 
Chronic ventricular pacing increases Cai at late activation sites which helps to activate IKAS to 
shorten the APD and maintain repolarization reserve.  Inhibiting IKAS significantly lengthens 
the APD at late activation sites and increases VF vulnerability. IKAS blockade may contribute to 
the underlying mechanism of sudden cardiac death in patients with permanent ventricular 
pacing.  
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Figure 1. Evolution of CM over 28 days of ventricular pacing (VP). Depicted is lead II from a 
rabbit heart with RV pacing and with LV pacing (A) showing the T-wave at baseline, and a flat 
or inverted T-wave after pacing was discontinued on day 28.  (B) Amount of fibrosis from 
Masson’s trichrome staining of ventricular tissue samples from structurally normal hearts 
(control) and chronically paced hearts. Summary data shows that there was no significant 
difference in fibrosis levels between the CM model and the control group. 
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Figure 2.  APD distribution before and after IKAS blockade by apamin. Optical Vm 
mapping was performed during RA pacing at a 300 ms PCL.  A shows APD tracings (first row) 
from site A marked in the color maps below.  Example APD80 maps are shown at baseline 
(second row), after apamin (100 nmol/L) infusion (third row) and the ∆APD80 between baseline 
and apamin (4th row).  Arrows point to a significant lengthening of the APD80 at the late 
activation site in both RV and LV paced ventricles. Asterisks indicate the sites of chronic 
pacing. B – Summary APD80 data showing that apamin prolonged the APD80 in normal and 
CM ventricles. C - Standard Deviation (SD) of APD80 is larger in CM ventricles compared to 
normal ventricles both before and after apamin infusion. Apamin significantly incresed the SD 
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of APD80 in CM ventricles, but not in normal ventricles.  D - APD80 was significantly 
prolonged after apamin infusion in CM ventricles compared to normal ventricles. 
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Figure 3. CaTD50 changes in normal and chronically paced hearts.  A - CaTD50 maps 
from optical mapping of rabbit hearts from both control and paced groups. Maps were 
recorded during atrial pacing (PCL of 300ms). Asterisks indicate the site of chronic ventricular 
pacing prior to explantation of the heart. B - Example Cai transient recordings show that the 
decay was prolonged in the CM model.  Summary data is shown in Panel C.   
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Figure 4. Effects of chronic pacing on Cai fluorescence transients in the CM model (A – RV 
pacing, B – LV pacing) as compared to control (C). All optical tracings were obtained during 
atrial pacing. Asterisks indicate the site of chronic ventricular pacing prior to explantation of 
the heart. Ca2+ fluorescence levels were increased at late activation sites compared to early 
activation sites near the location of chronic pacing in CM model (Panels A and B). However, 
the same was not observed in Panel C (normal control). 
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Figure 5. Ventricular vulnerability to fibrillation after IKAS blockade in normal and 
chronically paced ventricles (Protocol I).  A - Representative traces of Vm alternans in the 
CM model after apamin infusion. Corresponding AT and APD maps from two consecutive 
ventricular activations are shown. B - Apamin prolonged the PCL threshold of 2:2 alternans.  
C - VF inducibility was tested 4 times in each heart.  VF was able to be induced in all 10 
paced ventricles, and in 3 of the 5 normal ventricles. D - After apamin infusion, VF duration 
was longer in chronic paced hearts compared to control hearts.  The pacing sites during the 
mapping study were the same as that during chronic ventricular pacing ( ).  AT – 
activation time. 
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Figure 6.  Optical mapping of pacing-induced Tdp in Protocol II (AV block).  A – APD80 
maps and example signals at baseline and after apamin infusion in the CM model.  Shown is 
that the APD is significantly prolonged at a PCL of 1000 ms.  B - EAD beat induced TdP 
during short-long-short pacing after apamin infusion (300-2000-220ms). C - The earliest 
activation site of an TdP occurred at a site distal from the chronic pacing site. Red arrows 
point to the origin of the TdP.  An AT map is shown along with a fluorescence map which 
shows an area with light red color (Vm gradient change), which is the earliest activation site of 
the earliest TdP beat.  An APD80 map shows that the earliest activation site correlated to the 
longest APD. The pacing during optical mapping was performed from the same site as during 
chronic LV pacing ( ). 
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Figure 7.  Effect of IKAS blockade on the wave breaks during VF in the CM model.  Panels A 
and B show consecutive phase maps sampled at 20 ms during VF at baseline and after 
apamin infusion. Phase singularities (PS) are indicated by black arrowheads. A corresponding 
optical recording of VF from the site indicated by the asterisk is also shown. Note that the 
numbers of PS were significantly increased after apamin infusion. Summary data is shown in 
Panel C.   
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Figure 8. Protein and mRNA analyses. (A) Western blot analyses of the SK2 protein levels 
from chronically paced ventricles and in normal controls.  (B) There was no significant 
difference in the SK2 protein levels in paced ventricles compared to normal ventricles or 
between proximal and distal sites.  (C) RNA levels show a significant increase in SK2 and 
SK3 expression at the distal site compared to the proximal site.  
 
